ArticleClinical & translational immunology2024

Targeting CD38 with monoclonal antibodies disrupts key survival pathways in paediatric Burkitt's lymphoma malignant B cells.

Kathrin Kläsener et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.